BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 20673354)

  • 1. Increased entropy of signal transduction in the cancer metastasis phenotype.
    Teschendorff AE; Severini S
    BMC Syst Biol; 2010 Jul; 4():104. PubMed ID: 20673354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
    Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
    Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a co‑expression network for the analysis of aggressive and non‑aggressive breast cancer cell lines to predict the clinical outcome of patients.
    Guo L; Zhang K; Bing Z
    Mol Med Rep; 2017 Dec; 16(6):7967-7978. PubMed ID: 28944917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules.
    Teschendorff AE; Gomez S; Arenas A; El-Ashry D; Schmidt M; Gehrmann M; Caldas C
    BMC Cancer; 2010 Nov; 10():604. PubMed ID: 21050467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inferring gene dependency network specific to phenotypic alteration based on gene expression data and clinical information of breast cancer.
    Zhou X; Liu J
    PLoS One; 2014; 9(3):e92023. PubMed ID: 24637666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
    Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
    Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.
    Bemmo A; Dias C; Rose AA; Russo C; Siegel P; Majewski J
    PLoS One; 2010 Aug; 5(8):e11981. PubMed ID: 20700505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer.
    Yun J; Frankenberger CA; Kuo WL; Boelens MC; Eves EM; Cheng N; Liang H; Li WH; Ishwaran H; Minn AJ; Rosner MR
    EMBO J; 2011 Aug; 30(21):4500-14. PubMed ID: 21873975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways in breast cancer metastasis - novel insights from functional genomics.
    Blanco MA; Kang Y
    Breast Cancer Res; 2011 Mar; 13(2):206. PubMed ID: 21457525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
    Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
    Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of significant pathways in breast cancer metastasis via module extraction and comparison.
    Wang X; Qian H; Zhang S
    IET Syst Biol; 2014 Apr; 8(2):47-55. PubMed ID: 25014225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer.
    Banerji CR; Severini S; Caldas C; Teschendorff AE
    PLoS Comput Biol; 2015 Mar; 11(3):e1004115. PubMed ID: 25793737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
    Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
    Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating cellular network heterogeneity and modularity in cancer: a network entropy and unbalanced motif approach.
    Cheng F; Liu C; Shen B; Zhao Z
    BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):65. PubMed ID: 27585651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression module analysis reveals biological processes, genomic gain, and regulatory mechanisms associated with breast cancer progression.
    Shi Z; Derow CK; Zhang B
    BMC Syst Biol; 2010 May; 4():74. PubMed ID: 20507583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of aggressive behavior of breast cancer via an integrated gene regulatory network.
    Yang X; Jia M; Li Z; Lu S; Qi X; Zhao B; Wang X; Rong Y; Shi J; Zhang Z; Xu W; Gao Y; Zhang S; Yu G
    J Cancer Res Ther; 2014; 10(4):1013-8. PubMed ID: 25579546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
    Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network-based classification of breast cancer metastasis.
    Chuang HY; Lee E; Liu YT; Lee D; Ideker T
    Mol Syst Biol; 2007; 3():140. PubMed ID: 17940530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.